Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Adriaan Van Bokhoven to Molecular Sequence Data

This is a "connection" page, showing publications Adriaan Van Bokhoven has written about Molecular Sequence Data.

 
Connection Strength
 
 
 
0.066
 
  1. Verhaegh GW, van Bokhoven A, Smit F, Schalken JA, Bussemakers MJ. Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene. J Biol Chem. 2000 Dec 01; 275(48):37496-503.
    View in: PubMed
    Score: 0.008
  2. Span PN, van Bokhoven A, Smals AG, Sweep CG, Schalken JA. Partial sequencing and tissue distribution of the canine isoforms of steroid 5alpha-reductase type I and type II. Prostate. 2000 Aug 01; 44(3):233-9.
    View in: PubMed
    Score: 0.008
  3. Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999 Dec 01; 59(23):5975-9.
    View in: PubMed
    Score: 0.008
  4. Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A, Schalken JA. Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun. 1997 Dec 18; 241(2):453-8.
    View in: PubMed
    Score: 0.007
  5. Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Debruyne FM, Schalken JA. p16 mutations/deletions are not frequent events in prostate cancer. Br J Cancer. 1996 Jul; 74(1):120-2.
    View in: PubMed
    Score: 0.006
  6. Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJ, van Bokhoven A, van Roy F. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics. 1995 Mar 20; 26(2):281-9.
    View in: PubMed
    Score: 0.006
  7. Bussemakers MJ, Giroldi LA, van Bokhoven A, Schalken JA. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. Biochem Biophys Res Commun. 1994 Sep 15; 203(2):1284-90.
    View in: PubMed
    Score: 0.005
  8. Roebroek AJ, van de Velde HJ, Van Bokhoven A, Broers JL, Ramaekers FC, Van de Ven WJ. Cloning and expression of alternative transcripts of a novel neuroendocrine-specific gene and identification of its 135-kDa translational product. J Biol Chem. 1993 Jun 25; 268(18):13439-47.
    View in: PubMed
    Score: 0.005
  9. Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R, Schalken JA. Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep. 1993 Feb; 17(2):123-8.
    View in: PubMed
    Score: 0.005
  10. Bussemakers MJ, Verhaegh GW, van Bokhoven A, Debruyne FM, Schalken JA. Differential expression of vimentin in rat prostatic tumors. Biochem Biophys Res Commun. 1992 Feb 14; 182(3):1254-9.
    View in: PubMed
    Score: 0.004
  11. Bussemakers MJ, van Bokhoven A, van Groningen JJ, Debruyne FM, Schalken JA. Increased expression of retroviral sequences in progressionally advanced rat prostatic tumors. Biochem Biophys Res Commun. 1992 Jan 15; 182(1):318-24.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)